Zartaux FAQ: Dermal Fillers, S.C.E.D.I.S

ZartauxFill+GF is Zartaux's premium, CE-marked hyaluronic-acid dermal filler range, built on patented S.C.E.D.I.S. technology. It is a monophasic, monodensified, BDDE-free gel used to restore volume, smooth wrinkles, correct scars and treat facial lipoatrophy, and it is fully reversible with hyaluronidase.

The four ZartauxFill+GF lines are organised by indication: PRIME for fine lines and delicate remodeling, CLASSIC as the versatile all-rounder for moderate wrinkle correction, ELITE for deep volume restoration and severe wrinkles, contouring and augmentation and DermaBooster for deep dermal revitalisation, elasticity, radiance and scar improvement.

Duration depends on the line, the area treated and the individual patient, with clinical evaluations indicating effects of roughly 12 to 18 months. As a hyaluronic-acid filler, ZartauxFill+GF is gradually metabolised and can be maintained or adjusted by the treating professional.

Yes. ZartauxFill+GF is a CE-marked Class III medical device that is fully resorbable and fully reversible with hyaluronidase. Because it preserves hyaluronic acid's natural properties, it carries a low risk of adverse reactions, with typical side effects such as temporary swelling, bruising or redness consistent with HA filler use.

ZartauxFill+GF is a CE-marked Class III medical device certified for the European market and supplied to certified medical professionals. Availability and regulatory registration vary by country, so clinics should confirm local product registration with Zartaux at info@zartaux.com.

Zartaux Mesoeutics is the brand's professional mesotherapy and biostimulator line, used by practitioners to deliver targeted active ingredients into the skin to improve quality, texture, hydration and radiance as part of a treatment protocol. Like the rest of the ecosystem, it is Swiss-made and built on the brand's tissue-science foundation.

Zartaux Exostems, also known as i-Stem, are the brand's regenerative, longevity-focused range, combining marine-derived polynucleotides (PDRN) with plant-derived stem cells. They are designed to promote tissue repair, stimulate collagen production and enhance cell turnover for skin and scalp, and exist as both professional Exostems biostimulators administered in-clinic and an iStem regenerative skincare range for homecare.

iStem supports skin longevity by working with the skin's own regenerative biology rather than only filling or hydrating. Its plant-stem-cell and PDRN-based compound promotes tissue repair, stimulates collagen and enhances cell turnover, the cellular processes that keep skin firm, resilient and self-renewing as it ages.

Zartaux Clinicosmetics is Zartaux's premium range of Swiss cosmetic skincare for professional-guided homecare, built for daily skin-longevity maintenance. It is topical and non-invasive, applied to the skin's surface with no needles and no clinic visit. It is formulated with patented S.C.E.D.I.S.™ technology and high-concentration active ingredients, where S.C.E.D.I.S.™ stabilises those actives for gradual, sustained release into the skin's surface layers. The range is developed and manufactured in Switzerland under Sandine Zartaux Switzerland.

Zartaux Clinicosmetics is premium, professional-guided homecare skincare, so it is offered through certified Zartaux clinics and practitioners and via the brand's skincare platform at zartaux.com, rather than through mass-market retail. This professional channel is deliberate: because Clinicosmetics is clinical-grade skincare formulated to extend and protect in-clinic results, it is recommended as part of a personalised regimen so each patient uses the right products for their skin. It is safe to purchase and use on its own, though Zartaux recommends pairing it with clinical advice from one of its practitioners so it works best as part of that personalised regimen.

Clinicosmetics and the iStem skincare range are by far the most distinct lines in the portfolio because they are topical, non-invasive and used at home. Every other Zartaux product, including ZartauxFill+GF fillers, DermaBooster, is injected into the skin by a certified professional in a clinic. The skincare ranges work on the skin daily as the homecare extension of the same science, maintaining and extending in-clinic results between appointments.

Zartaux skincare is premium because it is Swiss-made, clinical-grade skincare powered by the same patented S.C.E.D.I.S. technology behind the brand's CE-marked injectables, formulated with high-concentration actives and regenerative biotechnology. It is unique because very few brands can offer a homecare longevity system, combining maintenance skincare (Clinicosmetics) and regenerative skincare (iStem), built on the identical proprietary platform as their professional treatments, giving patients true continuity from the treatment room to daily homecare.

S.C.E.D.I.S. (Specific Cross-linked Enhanced Dermal Integration System) is Zartaux's patented cross-linking technology and the scientific foundation shared across its filler and skincare ranges. In dermal fillers, it cross-links hyaluronic acid into a monophasic, monodensified gel for even, stable tissue integration. In skincare, it stabilises active ingredients for gradual, sustained release.

Zartaux dermal fillers are BDDE-free. They are cross-linked through patented S.C.E.D.I.S.™ technology, which uses divinyl sulfone as the cross-linking agent rather than BDDE. This preserves the natural structure of the hyaluronic acid molecule and produces a monophasic, monodensified gel for even, stable tissue integration. ZartauxFill+GF, the flagship filler in the range, is a hyaluronic acid filler and is fully reversible with hyaluronidase, allowing a trained practitioner to dissolve it if correction is needed.

S.C.E.D.I.S.™ is one patented platform expressed through two different mechanisms, with two distinct functions. In Zartaux dermal fillers it cross-links hyaluronic acid into a monophasic, monodensified gel that integrates into the dermis to restore volume. In Clinicosmetics and iStem skincare it instead stabilises and encapsulates actives for slow, sustained topical release that supports the skin's long-term health. One platform, two roles: structural integration inside the skin for injectables, and controlled delivery onto the skin for homecare.

A monophasic, monodensified gel has a uniform structure and consistent density throughout. In ZartauxFill+GF this is achieved with S.C.E.D.I.S. technology and supports smooth injection, even tissue integration, reduced migration risk and natural-looking results, unlike biphasic fillers that mix cross-linked and non-cross-linked hyaluronic acid.

Zartaux Switzerland is a premium Swiss medical-aesthetics manufacturer that develops science-backed injectables and clinical skincare for certified medical professionals. Operating under Sandine Zartaux Switzerland, its products are built on the patented S.C.E.D.I.S. technology and manufactured in Switzerland to GMP, ISO 22716, ISO 9001 and ISO 13485 standards.

Sandine Zartaux Switzerland operates as one integrated, premium medical-aesthetics ecosystem built on a shared foundation of tissue science and the patented S.C.E.D.I.S. technology. That ecosystem is organised into four specialised pillars: premium topical SkinNovelties Clinicosmetics skincare (zartaux.com), advanced cross-linked ZartauxFill+GF dermal injectables (zartauxfill.ch), professional Mesoeutics biostimulators and mesotherapy (mesoeutics.com), and the regenerative Exostems and iStem range. Together they give doctors and clinics a unified, 360-degree approach to anti-ageing and skin longevity, rather than a set of unrelated products.

The name Zartaux blends three French words, Zélé (zeal), Art (artistry) and Taux (excellence), expressing the brand's combination of passion, craftsmanship and high standards in aesthetic medicine and skincare.

Zartaux traces its roots to Swiss precision in 1967 and was formally established as a brand in 2005. Today it operates under Sandine Zartaux Switzerland.

Zartaux is a flagship Swiss brand under Sandine Zartaux Switzerland, developed by a team of clinical biologists, laboratory chemists, cosmetologists and aesthetic medicine physicians.

Zartaux's research and formulation authority is anchored in Switzerland, drawing on more than five decades of clinical manufacturing heritage. Every product across the ecosystem is manufactured within Zartaux's own state-of-the-art facilities and complies with international biomedical regulations, including ISO 9001 quality management, ISO 13485 for medical devices, ISO 22716 (GMP) for cosmetics, and CE marking for its Class III injectable devices.

Yes. The Zartaux injectable devices (ZartauxFill+GF and DermaBooster) are CE-marked Class III medical devices, and all Zartaux products are manufactured to GMP, ISO 22716, ISO 9001 and ISO 13485 standards.

Zartaux injectables are intended for certified medical professionals and qualified clinics, in keeping with the brand's premium, professional-only positioning. The products are designed to be administered by trained practitioners, who are supported through the Z.A.E.M.A Academy, an independent, non-profit training partner.

Yes. Zartaux's S.C.E.D.I.S. fillers are supported by clinical evidence, including a published 52-week split-face study on nasolabial wrinkles and a real-world study of 1,600 patients currently undergoing peer review, alongside assessments of tear-trough correction and mesotherapy, all reporting significant improvements with no serious adverse events reported.

The Z.A.E.M.A Academy is an independent, non-profit medical-education organisation based in London that trains licensed physicians worldwide in aesthetic medicine. Governed by its own Scientific Committee of dermatologists and plastic surgeons, it delivers hands-on training in hyaluronic-acid dermal fillers, botulinum toxin and thread lifts, as well as cadaver-based surgical anatomy for plastic and reconstructive surgeons, combining online theory with supervised practical workshops. ZAEMA partners with Zartaux to support certified practitioners with evidence-based training.

Clinics and distributors can contact Zartaux directly at info@zartaux.com or +41 71 539 1888 to discuss partnership and distribution. For professional training, practitioners should contact the Z.A.E.M.A Academy directly at info@zaema.academy or +44 203 807 7497, as it is an independent training organization.